FEDERALhearing transcript

Senate Hearing on the Future of Precision Medicine

Original title: CONTINUING AMERICA'S LEADERSHIP: REALIZING THE PROMISE OF PRECISION MEDICINE FOR PATIENTS

January 1, 2017

precision medicine healthcare genetics medical research cancer treatment health technology

Track this bill to get notified when it advances a stage. One tap to stop, anytime.

The Frame

What this does

This hearing established the legislative foundation for federal support and regulatory frameworks for , which aims to shift healthcare from generalized treatments to personalized therapies based on individual DNA.

Who is mentioned in the record

Potentially affected actors named in the source documents. Mention is not a position.

Patients with genetic-based diseases

These individuals may receive personalized treatment plans based on their specific genetic mutations.

Medical research institutions

These organizations are involved in the development and application of genetic sequencing and precision therapies.

What changed

Last recorded activity January 1, 2017.

What's next

Next step not available in the current record.

Summary

The Senate Committee on Health, Education, Labor, and Pensions held a hearing on May 5, 2015, to discuss the development and implementation of . The hearing explored how tailoring medical treatments to an individual's genetic makeup can improve patient outcomes, particularly in areas like diabetes and cancer treatment.

Key Facts

The hearing took place on May 5, 2015, in the Dirksen Senate Office Building.
Precision medicine involves using an individual's DNA and genetic makeup to tailor medical treatments.
The committee discussed the use of genetic sequencing to treat specific mutations in cancer cells.
Major cancer centers like Sloan-Kettering, Dana-Farber, and MD Anderson have begun automatically sequencing tumors for incoming patients.
The hearing included testimony from the NIH, the Office of the National Coordinator for Health Information Technology, and the FDA.

Frequently Asked Questions

What is precision medicine?

It is a medical approach that uses a patient's individual genetic and molecular information to customize treatments, rather than using a one-size-fits-all approach.

Why is the Senate discussing this?

The committee is exploring how to support the development of these technologies and ensure they are safely and effectively available to patients.

Why It Matters

News Coverage

No news coverage found yet. Articles are indexed twice daily.

Discoveries

Patterns POLISCOPE noticed across the record. These are observations to investigate, not conclusions.

policy shift90% confidence

Shift toward personalized medicine

The hearing marks a formal legislative interest in moving away from generalized disease treatment toward genetic-based personalized medicine.

National Institutes of Health Food and Drug Administration

Connected Entities

organizationFood and Drug Administration“Federal agency regulating medical devices and drugs”Map →

personKaren B. DeSalvo“National Coordinator for Health Information Technology”Map →

personLamar Alexander“Chairman of the Committee on Health, Education, Labor, and Pensions”Map →

personJeffrey Shuren“Director of the Center for Devices and Radiological Health at the FDA”Map →

organizationNational Institutes of Health“Federal agency involved in medical research”Map →

personPatty Murray“U.S. Senator from Washington”Map →

personFrancis S. Collins“Director of the National Institutes of Health”Map →

Sources

Open source document

www.govinfo.gov

Analysis Score

0–100

Significance65
How much this matters to a regular citizen
Controversy10
Intensity of disagreement among stakeholders
Entertainment5
Compellingness for a non-policy-wonk reader
Buzz15
Current news / social attention level

Publisher tools